Satralizumab Biosimilar - Research Grade,ichor.bio,ICH5106
Detects human IL-6R
Host
CHO Cells
Reactivity
Human
Platform ID
BAB326631171
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Specifications
NameSatralizumab Biosimilar - Research Grade
Cat. No.ICH5106
HostCHO Cells
IsotypeHuman IgG2(C131S/R133K/E137G/C219S/H264Q/R351Q/S374A/Q415E/N430A)-Kappa
ReactivityHuman
Concentration5mg/ml
TargetIL-6R
Purity≥95% monomer by analytical SEC, >95% by SDS Page
Endotoxin Level<1EU/mg Determined by LAL gel clotting assay
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only
Scientific Background
Uses the same sequence as the therapeutic antibody Satralizumab
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.